Zhi Hong
Chief Executive Officer at BRII BIOSCIENCES LIMITED
Net worth: 5 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Nelsen | M | 60 |
Brii Biosciences (Beijing) Co. Ltd.
Brii Biosciences (Hong Kong) Co. Ltd.
Brii Biosciences Ltd.
 Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
 Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | 6 years |
| Yong Qing Luo | M | 54 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | 4 years |
| An Kang Li | M | 47 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 4 years |
| Martin Murphy | M | 81 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Hui Tang | F | 64 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Yiu Wa Tsui | M | 74 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Gregg Alton | M | 58 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 3 years |
| Emma Walmsley | F | 55 | 14 years | |
| Phil Thomson | M | - | 13 years | |
| Li Yan | M | 57 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 6 years |
| Agnieszka Gallagher | F | 51 |
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 7 years |
| Lisa Trivison Beck | F | 62 | 31 years | |
| Tony Wood | M | - | 7 years | |
| Axel Bouchon | M | 52 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 2 years |
| Deborah Waterhouse | F | 57 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 7 years |
| Jesse Goodman | M | 72 | 8 years | |
| Karen D. Neuendorff | M | 49 |
Brii Biosciences Ltd.
Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC. | 2 years |
| Hal Barron | M | 62 | 6 years | |
| Qing Zhu | M | 57 | 6 years | |
| David Margolis | M | - | - | |
| Tai Yin Yang | M | 70 | 2 years | |
| Chris Fang | M | - | - | |
| Darcie Robinson | F | - | - | |
| Shobie Ramakrishnan | F | - | 6 years | |
| Summer Li | F | - | - | |
| Frannie DeFranco | F | - | 14 years | |
| Groot Eleanor de | M | - |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | - |
| Skuban Aleksandar | M | - |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | - |
| Yao Zhang | M | - | - | |
| Anita Kidgell | F | - | 16 years | |
| Yacov Shamash | M | 74 |
The State University of New York
| 32 years |
| Susannah Cantrell | M | - | 2 years | |
| Jean-Luc Samuel Francois Girardet | M | 57 | 6 years | |
| Lian Hong Xu | M | 58 | 6 years | |
| Diana Conrad | F | - | 8 years | |
| Kimberly Smith | M | - |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 11 years |
| Lin Ni | F | - |
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd.
Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. Pharmaceuticals: MajorHealth Technology Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd. engages in research and development of medical technology. The company was founded by Zhi Hong on April 19, 2018 and is headquartered in Shanghai, China. | - |
| María Cristina de Luna Basagoiti | F | - | 14 years | |
| Luke Miels | M | - | 7 years | |
| Wing Tsz Ho | F | 54 | 3 years | |
| David Redfern | M | 57 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 13 years |
| Victoria Whyte | F | - | 15 years | |
| Russell W. Bessette | M | - |
The State University of New York
| 35 years |
| Hong Ling | M | 64 |
Fudan University
| 40 years |
| Carmen R. Rodriguez | F | 75 | 14 years | |
| Mitchell H. Pally | M | - |
The State University of New York
| 35 years |
| Hansen A. Yuan | M | 80 |
The State University of New York
| 34 years |
| Brian Johns | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Barry Quart | M | 67 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 7 years |
| Kimberly Manhard | F | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 10 years |
| Thomas Mount | M | - | 7 years | |
| Philip Hampton | M | 70 | 4 years | |
| Andrew Witty | M | 59 | - | |
| Julian Heslop | M | 70 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 13 years |
| Moncef Slaoui | M | 64 | 11 years | |
| Stephanie Burns | M | 69 | 9 years | |
| Richard J. Ablin | M | - |
The State University of New York
| 6 years |
| Roy Anderson | M | 76 | 11 years | |
| Jean-Luc Girardet | M | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | - |
| Shi Lian Wang | M | 64 |
Fudan University
| 6 years |
| William Louv | M | - | 21 years | |
| Jing Ulrich | F | 56 | - | |
| Michael W. Williams | M | - |
The State University of New York
| 6 years |
| Mei Sheng Zhou | M | 66 |
Fudan University
| 6 years |
| Qing Yu Wang | M | 65 |
Fudan University
| 4 years |
| Sarah Elton-Farr | F | - | 4 years | |
| Hai Bo Wang | M | 63 |
Fudan University
| 6 years |
| Chris Montclare | M | - |
The State University of New York
| 5 years |
| Anjali Bansal | F | 53 | 6 years | |
| Jiang Nan Cai | M | 67 |
Fudan University
| 2 years |
| Murray Stewart | M | 63 | 17 years | |
| Balbir Kelly Bisla | F | - | 4 years | |
| Chen Mao | M | 61 |
Fudan University
| 6 years |
| Stephany Yu | F | - |
Fudan University
| 7 years |
| Ravi Rao | M | 55 | 7 years | |
| Daniel Podolsky | M | 70 | 10 years | |
| Geoffrey Glass | M | 50 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 4 years |
| Lynn Elsenhans | F | 68 | 10 years | |
| Crispin Davis | M | 75 | 10 years | |
| Robert Rosewell Chai-Onn | M | 52 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | 6 years |
| Judy Lewent | F | 75 | 10 years | |
| Jean-Pierre Garnier | M | 75 | 8 years | |
| H. Culp | M | 60 | 9 years | |
| Laurie Glimcher | M | 72 | 5 years | |
| Deryck Charles Maughan | M | 76 | 12 years | |
| Ian Maurice Gray Prosser | M | 81 | 9 years | |
| Robert Wilson | M | 81 | 11 years | |
| Christopher Gent | M | 75 | 11 years | |
| Tom de Swaan | M | 78 | 9 years | |
| Saul Charles Klein | M | 53 | 2 years | |
| Gerardus Johannes Wijers | M | 74 | 3 years | |
| John Pottage | M | 71 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | 10 years |
| Simon Dingemans | M | 61 | 8 years | |
| Stephen Benkovic | M | - | 9 years | |
| William Rieflin | M | 64 | 5 years | |
| Christopher Viehbacher | M | 64 | 20 years | |
| Dame Cox | F | 64 | 6 years | |
| Vindi Banga | M | 69 | 7 years | |
| Urs Rohner | M | 65 | 9 years | |
| Robert Carr | M | - | 26 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 52 | 52.00% |
| United States | 25 | 25.00% |
| Cayman Islands | 23 | 23.00% |
| China | 13 | 13.00% |
| Hong Kong | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Zhi Hong
- Personal Network
